Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

ClinicalTrials.gov ID: NCT01148017

Public ClinicalTrials.gov record NCT01148017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 1:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective was to evaluate the persistence of bactericidal antibodies in children 40 and 60 months of age previously enrolled in the V59P14 (NCT00474526) study who received Novartis MenACWY Conjugate Vaccine. The study also enrolled age-matched subjects who have never received any meningococcal vaccine (naïve subjects) to serve as a control group. In addition, the response of a booster dose at 60 months was evaluated.

Study identification

NCT ID
NCT01148017
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Vaccines
Industry
Enrollment
433 participants

Conditions and interventions

Eligibility (public fields only)

Age range
37 Months to 63 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2010 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Apr 2013 (Actual)
Last update posted
Aug 14, 2017

2010 – 2013

United States locations

U.S. sites
19
U.S. states
7
U.S. cities
18
Facility City State ZIP Site status
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615 Birmingham Alabama 35205 —
Premier Health Research 9317 Firestone Blvd. Downey California 90241 —
Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624 Oakland California 94611 —
Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308 Paramount California 90723 —
Center for Clinical Trials, LLC 16660 Paramount Blvd., Suite 301 Paramount California 90723 —
Kaiser Permanente Pleasanton 7601 Stoneridge Drive, Second Floor Pleasanton California 94588 —
Kaiser Permanente San Francisco 2200 O'Farrell St., Sixth Floor San Francisco California 94115 —
Kaiser Permanente Santa Clara 710 Lawrence Expressway, Pediatric Clinic Department Santa Clara California 95051 —
Children's Memorial Hospital 2300 Children's Plaza, Box 155 Chicago Illinois 60614 —
Kentucky Pediatric/Adult Research 201 South Fifth Street, Suite 102 Bardstown Kentucky 40004 —
28 Annapolis Pediatrics, 200 Forbes Street, Suite 200 Annapolis Maryland 21401 —
Senders Pediatrics 2054 South Green Road Cleveland Ohio 44121 —
Pediatric Medical Associates 160 West Germantown Pike Suite D2 East Norriton Pennsylvania 19402 —
Children's Health Care 2501 West 12th Street Erie Pennsylvania 16505 —
Pennridge Pediatric Associates 270 Main Street Harleysville Pennsylvania 19438 —
Kid's Way Pediatrics 3068 Innovation Way Hermitage Pennsylvania 16148 —
Pediatric Medical Associates 1077 Rydal Road Suite 300 Rydal Pennsylvania 19046 —
Pennridge Pediatric Associates 711 Lawn Avenue Sellersville Pennsylvania 18960 —
PEAK Research 2859 Washington Rd., Ste. 412B Upper Saint Clair Pennsylvania 15241 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01148017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2017 · Synced Nov 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01148017 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →